Capricor Therapeutics Inc...

NASDAQ: CAPR · Real-Time Price · USD
7.96
0.18 (2.31%)
At close: Aug 15, 2025, 3:59 PM
8.00
0.57%
After-hours: Aug 15, 2025, 07:58 PM EDT

Capricor Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-44.06M -55.06M -40.47M -34.11M -27.95M -24.31M -22.29M -29.25M -29.23M -28.97M -29.02M -27.49M -25.05M -22.69M -20.02M -18.01M -17.99M -16.72M
Depreciation & Amortization
234.63M 1.5M 1.43M 1.36M 1.27M 1.17M 1.07M 952.88K 813.43K 670.74K 533.13K 420.17K 347.87K 288.05K 245.7K 209.13K 180.61K 161.05K
Stock-Based Compensation
7.52B 12.24M 9.77M 9.33M 9M 8.46M 7.39M 6.68M 6.05M 5.59M 4.46M 4.09M 3.72M 3.28M 2.97M 2.66M 2.43M 2.42M
Other Working Capital
-10.24B -10.24B -10.25B -10.25B -17.54M -17.37M -575.09M -573.01M -568.23M -565.15M 28.18M 28.29M 29.38M 29.71M -744.42M -713.28M -712.75M -711.81M
Other Non-Cash Items
-7.74B -127.41K -6.34M 6.39M 6.74M 6.74M 12.82M 13.83K 37.64K 31.47K 196.01K -13.21M -12.02M -12.32M -12.37M 1.65M 737.49K 1.51M
Deferred Income Tax
n/a n/a n/a -12.84M -12.84M -12.84M -12.84M 5.39K n/a n/a n/a 13.52M 13.52M 13.52M 13.52M n/a n/a n/a
Change in Working Capital
81.23K -3.71M -10.45M -12.99M -16.24M -16.37M -11.75M 690.82K 4.53M 7.76M 28.75M 28.86M 29.23M 29.71M 182.34K 435.54K 1.04M 1.98M
Operating Cash Flow
-32.87M -45.16M -40M -36.79M -33.95M -31.08M -25.6M -20.9M -17.8M -14.92M 4.92M 6.19M 8.54M 10.57M -16.81M -15.02M -14.66M -12.17M
Capital Expenditures
-1.93M -2.01M -1.54M -1.53M -2.11M -2.26M -2.05M -2.54M -3.01M -3.19M -3.36M -2.51M -1.87M -1.78M -1.2M -1.12M -799.51K -584.51K
Cash Acquisitions
n/a n/a n/a 5.13M -3.22M -9.91M 95.51M 1.45B 1.46B 1.5B 1.4B 38.08M 35M n/a n/a n/a n/a n/a
Purchase of Investments
-69.19B -69.2B -69.22B -69.1B -93.86M -95.85M -97.44M -104.71M -118.07M -149.02M -114.22M -82.18M -49.01M n/a n/a 6.13M n/a n/a
Sales Maturities Of Investments
81.79M 112.64M 93.8M 96.72M 103.02M 96.93M 104.6M 123.36M 125.29M 114.55M 82.51M 44.1M 14.01M n/a n/a -12.12M n/a n/a
Other Investing Acitivies
69.69B 69.69B 69.63B 69.62B -52.51M -45.81M -95.51M -1.45B -1.46B -1.5B -1.46B -95.82M -92.74M -57.74M n/a 5.99M n/a -107.46K
Investing Cash Flow
-97.49M -82.79M -116.18M 1.34M 7.05M -1.18M 5.11M 16.11M 4.22M -37.66M -35.07M -40.58M -36.87M -1.78M -1.2M -1.12M -799.51K -584.51K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
121K 202.22K 202.22K 205.24K 84.25K 60.71K 64.6K 87.89K 89.41K 46.73K 70.3K 86.36K 90.05K 75.05K 49.02K 67.9K 287.18K 5.95M
Financial Cash Flow
148.46M 150.53M 152.77M 94.85M 27.75M 27.87M 25.58M 5.36M 7.02M 4.85M 4.87M 1.97M 6.65M 7.67M 20.23M 21.68M 17.29M 41.41M
Net Cash Flow
18.11M 22.58M -3.41M 59.39M 851.23K -4.39M 5.09M 571.01K -6.56M -47.73M -25.28M -32.43M -21.68M 16.45M 2.22M 5.54M 1.83M 28.66M
Free Cash Flow
-34.81M -47.18M -41.53M -38.33M -36.05M -33.33M -27.64M -23.45M -20.8M -18.11M 1.56M 3.69M 6.66M 8.78M -18.01M -16.14M -15.46M -12.75M